Lupin LimitedNSE: LUPIN

Press Release Sep 18 2024

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated September 18, 2024, titled "Lupin Enters into a Non-Exclusive Patent Licensing Agreement with Takeda toCommercialize Vonoprazan, a Novel Gastrointestinal Drug in India".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases